18 studies found for:    teriflunomide
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Glatiramer Acetate (GA)
2 Completed
Has Results
Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for Teriflunomide);   Drug: Interferon-β
3 Recruiting Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Condition: Multiple Sclerosis
Intervention: Drug: TERIFLUNOMIDE HMR1726
4 Completed Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (placebo for teriflunomide)
5 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
6 Completed
Has Results
Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide)
7 Active, not recruiting Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide)
8 Active, not recruiting
Has Results
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Placebo (for teriflunomide);   Drug: Teriflunomide
9 Completed
Has Results
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Interferon-β [IFN-β];   Drug: Glatiramer Acetate [GA]
10 Active, not recruiting Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide (HMR1726)
11 Completed
Has Results
Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
Condition: Multiple Sclerosis
Interventions: Drug: teriflunomide;   Drug: Interferon-β-1;   Biological: Influenza vaccine
12 Not yet recruiting A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide HMR1726;   Drug: cholestyramine
13 Active, not recruiting
Has Results
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: interferon β-1a;   Drug: teriflunomide
14 Recruiting Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
Condition: Multiple Sclerosis
Intervention: Other: MRI
15 Terminated Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Condition: Multiple Sclerosis Relapse
Interventions: Drug: Teriflunomide (HMR1726);   Drug: Matching placebo
16 Recruiting Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: teriflunomide HMR1726;   Drug: cholestyramine;   Drug: charcoal
17 Active, not recruiting Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide (HMR1726)
18 Completed Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
Condition: Renal Impairment
Interventions: Drug: Teriflunomide HMR1726;   Drug: Cholestyramine

Indicates status has not been verified in more than two years